274 related articles for article (PubMed ID: 24119685)
1. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.
Takahashi Y; Fukuda Y; Yoshimura J; Toyoda A; Kurppa K; Moritoyo H; Belzil VV; Dion PA; Higasa K; Doi K; Ishiura H; Mitsui J; Date H; Ahsan B; Matsukawa T; Ichikawa Y; Moritoyo T; Ikoma M; Hashimoto T; Kimura F; Murayama S; Onodera O; Nishizawa M; Yoshida M; Atsuta N; Sobue G; ; Fifita JA; Williams KL; Blair IP; Nicholson GA; Gonzalez-Perez P; Brown RH; Nomoto M; Elenius K; Rouleau GA; Fujiyama A; Morishita S; Goto J; Tsuji S
Am J Hum Genet; 2013 Nov; 93(5):900-5. PubMed ID: 24119685
[TBL] [Abstract][Full Text] [Related]
2. ErbB4 Mutation that Decreased NRG1-ErbB4 Signaling Involved in the Pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
Sun L; Cheng B; Zhou Y; Fan Y; Li W; Qiu Q; Fang Y; Xiao S; Zheng H; Li X
J Alzheimers Dis; 2020; 74(2):535-544. PubMed ID: 32065797
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS).
Kwon Y; Kang M; Jeon YM; Lee S; Lee HW; Park JS; Kim HJ
J Neurol Sci; 2024 Feb; 457():122885. PubMed ID: 38278691
[TBL] [Abstract][Full Text] [Related]
4. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.
Takahashi Y; Uchino A; Shioya A; Sano T; Matsumoto C; Numata-Uematsu Y; Nagano S; Araki T; Murayama S; Saito Y
Neuropathology; 2019 Aug; 39(4):268-278. PubMed ID: 31124187
[TBL] [Abstract][Full Text] [Related]
5. Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Lopez-Font I; Sogorb-Esteve A; Javier-Torrent M; Brinkmalm G; Herrando-Grabulosa M; García-Lareu B; Turon-Sans J; Rojas-García R; Lleó A; Saura CA; Zetterberg H; Blennow K; Bosch A; Navarro X; Sáez-Valero J
Neurobiol Dis; 2019 Apr; 124():428-438. PubMed ID: 30594809
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.
Wu CH; Fallini C; Ticozzi N; Keagle PJ; Sapp PC; Piotrowska K; Lowe P; Koppers M; McKenna-Yasek D; Baron DM; Kost JE; Gonzalez-Perez P; Fox AD; Adams J; Taroni F; Tiloca C; Leclerc AL; Chafe SC; Mangroo D; Moore MJ; Zitzewitz JA; Xu ZS; van den Berg LH; Glass JD; Siciliano G; Cirulli ET; Goldstein DB; Salachas F; Meininger V; Rossoll W; Ratti A; Gellera C; Bosco DA; Bassell GJ; Silani V; Drory VE; Brown RH; Landers JE
Nature; 2012 Aug; 488(7412):499-503. PubMed ID: 22801503
[TBL] [Abstract][Full Text] [Related]
7. Mutations of optineurin in amyotrophic lateral sclerosis.
Maruyama H; Morino H; Ito H; Izumi Y; Kato H; Watanabe Y; Kinoshita Y; Kamada M; Nodera H; Suzuki H; Komure O; Matsuura S; Kobatake K; Morimoto N; Abe K; Suzuki N; Aoki M; Kawata A; Hirai T; Kato T; Ogasawara K; Hirano A; Takumi T; Kusaka H; Hagiwara K; Kaji R; Kawakami H
Nature; 2010 May; 465(7295):223-6. PubMed ID: 20428114
[TBL] [Abstract][Full Text] [Related]
8. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS.
Aoki M; Ogasawara M; Matsubara Y; Narisawa K; Nakamura S; Itoyama Y; Abe K
J Neurol Sci; 1994 Oct; 126(1):77-83. PubMed ID: 7836951
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
Adashek JJ; Pandya C; Maragakis NJ; De P; Cohen PR; Kato S; Kurzrock R
BMC Med; 2024 Feb; 22(1):74. PubMed ID: 38369520
[TBL] [Abstract][Full Text] [Related]
10. Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.
Zhou Q; Chen Y; Wei Q; Cao B; Wu Y; Zhao B; Ou R; Yang J; Chen X; Hadano S; Shang HF
Mol Neurobiol; 2017 Jul; 54(5):3189-3194. PubMed ID: 27056076
[TBL] [Abstract][Full Text] [Related]
11. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation.
Liu J; Allender E; Wang J; Simpson EH; Loeb JA; Song F
Neurobiol Dis; 2018 Mar; 111():118-126. PubMed ID: 29278738
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
13. Atypical Familial Amyotrophic Lateral Sclerosis with Slowly Progressing Lower Extremities-predominant Late-onset Muscular Weakness and Atrophy.
Togawa J; Ohi T; Yuan JH; Takashima H; Furuya H; Takechi S; Fujitake J; Hayashi S; Ishiura H; Naruse H; Mitsui J; Tsuji S
Intern Med; 2019; 58(13):1851-1858. PubMed ID: 31257275
[TBL] [Abstract][Full Text] [Related]
14. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
15. Molecular analyses of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan.
Aoki M; Abe K; Itoyama Y
Cell Mol Neurobiol; 1998 Dec; 18(6):639-47. PubMed ID: 9876871
[TBL] [Abstract][Full Text] [Related]
16. Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis.
Naruse H; Ishiura H; Mitsui J; Takahashi Y; Matsukawa T; Sakuishi K; Nakamagoe K; Miyake Z; Tamaoka A; Goto J; Yoshimura J; Doi K; Morishita S; Toda T; Tsuji S
Neurogenetics; 2021 Mar; 22(1):11-17. PubMed ID: 32815063
[TBL] [Abstract][Full Text] [Related]
17. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis.
Gellera C; Colombrita C; Ticozzi N; Castellotti B; Bragato C; Ratti A; Taroni F; Silani V
Neurogenetics; 2008 Feb; 9(1):33-40. PubMed ID: 18087731
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations.
Li H; Chou SJ; Hamasaki T; Perez-Garcia CG; O'Leary DD
Neural Dev; 2012 Feb; 7():10. PubMed ID: 22376909
[TBL] [Abstract][Full Text] [Related]
19. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred.
Williams KL; Durnall JC; Thoeng AD; Warraich ST; Nicholson GA; Blair IP
J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1286-8. PubMed ID: 19864664
[TBL] [Abstract][Full Text] [Related]
20. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
Giess R; Holtmann B; Braga M; Grimm T; Müller-Myhsok B; Toyka KV; Sendtner M
Am J Hum Genet; 2002 May; 70(5):1277-86. PubMed ID: 11951178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
